FX Conferences will be offering an audio conference entitled "Effective Licensing in the Wake of MedImmune v. Genentech" on January 29, 2009 from 11:30 AM to 12:30 PM (EDT). Dr. Michael Samardzija of Bracewell & Giuliani will explore the Supreme Court's decision in MedImmune v. Genentech, and the various decisions that have followed it, and provide attendees with ten drafting tips to decrease the risks associated with a licensee challenging the validity of a patent. The audio conference will focus on the licensing of life science technologies.
The registration fee for the webcast is $249. Those interested in registering for the audio conference, can do so here.
Comments